NervGen Pharma: NVG-291
A peptide drug aiming to lift scar-related ‘brakes’ on regeneration and plasticity after SCI. Here’s what the trial data actually suggests so far.
Read the report →
BEYOND PARALYSIS
SCI research news and deep dives. Hopeful, but data-led.
Latest News
- Story 1: (replace with your headline)
- Story 2: (replace with your headline)
- Story 3: (replace with your headline)
These link to external abstracts/articles. (Later we can store summaries on-site too.)